Answers are grounded in this paper and cite their sources.
In contrast to strong evidence-based clinical recommendations for lipid-lowering treatment, there is no analogous definitive diagnostic definition of hypercholesterolemia and its various subtypes. For many clinicians, guideline indications for hypolipidemic treatment can become broadly conflated with hypercholesterolemia in a non-specific sense. In this statement, we propose a unified definition and mechanism-based classification of hypercholesterolemia, which in turn should help to stratify patients and guide efficient diagnosis without interfering with the current strategies of ASCVD risk reduction.
No takes yet. Share an insight, caveat, or question.
Civeira et al. (2022) conducted a review in Hypercholesterolemia. Unified definition and mechanism-based classification of hypercholesterolemia was evaluated. A unified, mechanism-based definition and classification of hypercholesterolemia is proposed to guide patient stratification and diagnosis while preserving ASCVD risk reduction strategies.
Synapse has enriched 10 related papers. Consider them for comparative context: